Saturday, Jul 04, 2020 | Last Update : 02:25 AM IST

101st Day Of Lockdown

Maharashtra1929901046878376 Tamil Nadu102721583781385 Delhi92175630072864 Gujarat34686249411905 Uttar Pradesh2579717597749 West Bengal2048813571717 Karnataka197108807293 Rajasthan1878515043435 Telangana185709069275 Andhra Pradesh169347632206 Haryana1550911019251 Madhya Pradesh1410610815589 Bihar10911821184 Assam8956583212 Jammu and Kashmir76954856105 Odisha7316535333 Punjab56683989149 Kerala4594243626 Uttarakhand2791190937 Chhatisgarh2339193713 Jharkhand2339160512 Tripura140110931 Manipur13166390 Goa11984783 Himachal Pradesh9796179 Puducherry73930112 Nagaland5351820 Chandigarh4463676 Arunachal Pradesh182601 Mizoram1601230 Sikkim101520 Meghalaya50421
  Business   In Other News  19 Apr 2020  India will import drugs with less than 60 pc shelf life, condition apply

India will import drugs with less than 60 pc shelf life, condition apply

PTI
Published : Apr 19, 2020, 11:20 am IST
Updated : Apr 19, 2020, 11:20 am IST

Health ministry has instructed to take various steps to ensure availability of a sufficient quantity of drugs in the domestic retail market

 Drugs with less than 60 pc shelf life allowed to be imported on condition. (PTI Photo)
  Drugs with less than 60 pc shelf life allowed to be imported on condition. (PTI Photo)

New Delhi: Keeping in mind the coronavirus situation, the Central Drugs Standard Control Organisation (CDSCO) has allowed import of drugs with less than 60 per cent residual shelf life on the condition that importers give an undertaking that the drug would be utilised or consumed before the expiry date.

According to rules, the import of such drugs may be permitted after taking an undertaking from the importers by the port officers of CDSCO that the drug will be utilised or consumed before the expiry date and no part of it will be available for sale and distribution after its expiry, a circular issued to all port offices of CDSCO said.

 

"In the light of the present situation due to the COVID-19 outbreak, the health ministry has instructed to take various steps in order to ensure availability of a sufficient quantity of drugs in the domestic retail market, besides ensuring that the product conform to be of the prescribed specification. One of the steps is issuing immediate approvals to applications for registration, manufacture and import of pharmaceuticals.

"Further, we have received a representation from the industry association that there are challenges in the clearance at port offices due to the COVID-19 outbreak and many products are losing their shelf life and getting below the threshold of 60 per cent," the Drug Controller General of India (DCGI) said in a circular.

Therefore, it has been requested to relax the requirement of minimum 60 per cent residual shelf life of all drugs, including vaccines and biological products, at the time of import for a period of three months until normal supply resumes, the circular added.

According to rule 31 of the Drugs and Cosmetics Rules, 1945, "No drug shall be imported unless it complies with the standard of strength, quality and purity," provided that the licensing authority shall not allow the import of a drug with a less than 60 per cent residual shelf life as on the date of import.

However, in exceptional cases, the licensing authority may, for reasons to be recorded in writing, allow the import of any drug with a lesser shelf life, but before its expiry.

Tags: coronavirus, central drug standard control organisation (cdsco), drugs and cosmetic rules, aids drugs, union health ministry, indian pharmaceuticals, drug controller general of india (dcgi), vaccines
Location: India, Delhi, New Delhi